Processa Pharmaceuticals PCSA
NASDAQ PCSA
$1.55 -0.07 (-4.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Processa Pharmaceuticals (PCSA) Gains from Sales and Divestitures (2015)

Updated

Processa Pharmaceuticals (PCSA) posted Gains from Sales and Divestitures of $25,000 for FY2016, down 58.8% from $60,743 in FY2015.

Analysis

Processa Pharmaceuticals (PCSA) Gains from Sales and Divestitures (2015) Analysis & Trends

  • Business Quant data shows PCSA's Gains from Sales and Divestitures at $60,743 in FY2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Processa Pharmaceuticals 4.33 Mn 4.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 3,979.00
Sep 30, 2015 -44,128.00
Jun 30, 2015 -3,753.00
API Access

Processa Pharmaceuticals Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=PCSA&period=max&api_key=YOUR_API_KEY